Clinical trial / 2010
Switching to a cannabis vaporizer for one month improved respiratory symptoms and forced vital capacity in frequent cannabis users.
Twenty frequent cannabis users with respiratory symptoms were evaluated before and after 1 month of using a cannabis vaporizer. Among the 12 participants who did not develop a respiratory illness, respiratory symptoms significantly improved (t(11)=6.22, p=0.000065, d=3.75), as did forced vital capacity (FVC; t(11)=2.90, p=0.007, d=1.75). Forced expiratory volume in 1 second (FEV1) showed a non-significant improvement (t(11)=1.77, p=0.053, d=1.07).
- Study type
- Pre/post interventional study
- Who was studied
- 20 frequent cannabis users reporting at least two respiratory symptoms
- What was measured
- Severity of nine respiratory symptoms, spirometry measures (FEV1, FVC)
THE PAPER
Pulmonary function in cannabis users: Support for a clinical trial of the vaporizer.
Van Dam NT, Earleywine M. Int J Drug Policy, 2010.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.